Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

TNXPTNXP
3 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in TONIX PHARMACEUTICALS HLDG C

Point72 Asset Management, L.P. holds 1.2M shares of TNXP (TONIX PHARMACEUTICALS HLDG C), worth $14.9M as of 2026-Q2. The position was increased (+830.3% shares). TNXP represents 0.0% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$14.9M

Current Shares

1.2M

Total Value Change

+$5.2M

Total Shares Change

+546,719

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+830.3%
$14.9M0.0%$12.76
45
2026-Q1
Decreased
125,414
-79.8%
$1.7M0.0%$13.94
0
2025-Q4
New
620,033
-
$9.7M0.0%$15.82
38

Other major holders of TNXP: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used